Program
Preliminary program – Together VT Prague 2023
(as of April 28, 2023)
DAY 1 (Friday, June 16, 2023)
08:30–09:45
Chairs: T Deneke, J Kautzner
ECG remains the main tool to determine where to go
How to differentiate between right and left outflow tract in idiopathic VT? (T Deneke)
How to localize substrate and VT exit from reentry circuit in ischemic and non-ischemic heart disease? (F Marchlinski)
When to go epicardial? (P Della Bella)
Can body surface mapping help to improve the decision? (P van Dam)
Discussion
09:45–11:00
Chairs: P Della Bella, P Jais
Imaging is an important element in VT ablation
How much should we evaluate patients with clinically idiopathic PVC/VT? (D Muser)
The role of intracardiac echocardiography in structural heart disease VT? (J Kautzner)
The role of CT in structural heart disease VT? (P Jais)
The role of magnetic resonance in structural heart disease VT? (K Zeppenfeld)
Discussion
11:00–11:30 Coffee break
11:30–13:00
Chairs: K Zeppenfeld, F Marchlinski
Live cases of catheter ablation
1. Catheter ablation of structural heart disease VT using endo/epicardial approach with a support of electroanatomical mapping system CARTO
Petr Peichl
2. Catheter ablation of post infarction VT using Diamond Temp catheter and Ensite X system
Josef Kautzner
Live-in-the-box case
1. VT ablation using ultra-HD Rhythmia mapping system and Lumipoint module – tips and tricks.
Philippe Maury
13:00–14:00 Lunch
14:00–15:15
Chairs: F Sacher, P Peichl
Risk stratification in specific conditions
Arrhythmogenic right ventricular cardiomyopathy (E Gandjbakhch)
Mitral valve prolapse (A Sabbag)
Hypertrophic cardiomyopathy (M Brignole)
Channelopathies (A Krebsova)
Discussion
15:15–16:30
Chairs: A Frontera, T Deneke
Future directions – AI and VT management
Modelling of VT circuits (A Frontera)
What differentiates arrhythmogenic from non-arrhythmogenic myocardial scar? (N Trayanova)
A digital twin of the heart (T Deneke)
Is it all in the ECG? – AI and prediction of sudden cardiac death risk (TBD)
Discussion
16:30–17:00 Coffee break
17:00–18:00
Chairs: F Sacher, J Kautzner
Debates
Do we need percutaneous mechanical support for VT ablation?
Pro P Della Bella / con F Sacher plus rebuttal
Is high-density mapping necessary for successful VT ablation?
Pro A Frontera / con F Marchlinski plus rebuttal
18:00–19:00
Chairs: J Kautzner, K Zeppenfeld, P Della Bella
Case reports – young EP arena
5 interesting cases (5 plus 5) – will be selected
19:00 Get together reception
DAY 2 (Saturday, June 17, 2023)
08:30–09:45
Chairs: E Anter, C Meyer
Mapping strategies for catheter ablation
High-density mapping is essential to identify arrhythmogenic substrate (C Meyer)
Functional mapping is critically important for the description of the substrate (A Porta-Sanchez)
Voltage mapping is the most important component of substrate identification (E Anter)
Pacemapping is a key strategy to identify a critical part of the substrate (F Bogun)
Discussion
09:45–10:45
Chairs: E Anter, J Kautzner
VT management beyond catheter ablation
Management of recurrent VTs – how effective/risky are drugs? (Robert Hatala)
Optimizing device programming in VT patients (C Israel)
Stellate ganglium blockade (M Sramko)
Stereotactic radiotherapy after failed catheter ablation (J Kautzner)
Discussion
10:45–11:15 Coffee break
11:15–12:30
Chairs: T de Potter, F Bogun
Novel approaches to VT ablation
Pulsed field ablation – animal/clinical data (E Anter)
Ultra-low cryoablation (T de Potter)
Alcohol ablation (M Valderrabano)
Bipolar ablation (P Futyma)
Discussion
12:30–13:30 Lunch
13:30–14:30
Chairs: J Kautzner, K Zeppenfeld, P Della Bella
Case reports – young EP arena
5 interesting cases (5 plus 5)
14:30–15:45
Chairs: J Kautzner, F Bogun
VT ablation in specific situations
Previous correction for congenital heart disease (K Zeppenfled)
Brugada syndrome (P Jais)
Papillary muscle VT/PVC (P Peichl)
Sarcoidosis (F Bogun)
Discussion
15:45 Adjourn (J Kautzner, P Della Bella)
